Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 108, Issue 5, Pages 1827-1832Publisher
NATL ACAD SCIENCES
DOI: 10.1073/pnas.1015623108
Keywords
-
Categories
Funding
- Israel Science Foundation [1368/08]
- European Union
- Israel Ministry of Science, Culture and Sport
Ask authors/readers for more resources
Herein we investigated a new strategy for the modulation of cardiac macrophages to a reparative state, at a predetermined time after myocardial infarction (MI), in aim to promote resolution of inflammation and elicit infarct repair. The strategy employed intravenous injections of phosphatidylserine (PS)-presenting liposomes, mimicking the anti-inflammatory effects of apoptotic cells. Following PS-liposome uptake by macrophages in vitro and in vivo, the cells secreted high levels of anti-inflammatory cytokines [transforming growth factor beta (TGF beta) and interleukin 10 (IL-10)] and upregulated the expression of the mannose receptor-CD206, concomitant with downregulation of proinflammatory markers, such as tumor necrosis factor alpha (TNF alpha) and the surface marker CD86. In a rat model of acute MI, targeting of PS-presenting liposomes to infarct macrophages after injection via the femoral vein was demonstrated by magnetic resonance imaging (MRI). The treatment promoted angiogenesis, the preservation of small scars, and prevented ventricular dilatation and remodeling. This strategy represents a unique and accessible approach for myocardial infarct repair.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available